Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS

Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by specific loss of motor neurons in the spinal cord and brain stem. Although ALS has historically been characterized as a motor neuron disease, there is evidence that motor neurons degenerate in a retrograde manner, beginn...

Full description

Saved in:
Bibliographic Details
Main Authors: Adam Eckardt, Charles Marble, Bradley Fern, Henry Moritz, Charles Kotula, Jiayi Ke, Clarisse Rebancos, Samantha Robertson, Hiroshi Nishimune, Masatoshi Suzuki
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2025.1527181/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841525838708736000
author Adam Eckardt
Charles Marble
Bradley Fern
Henry Moritz
Charles Kotula
Jiayi Ke
Clarisse Rebancos
Samantha Robertson
Hiroshi Nishimune
Masatoshi Suzuki
Masatoshi Suzuki
author_facet Adam Eckardt
Charles Marble
Bradley Fern
Henry Moritz
Charles Kotula
Jiayi Ke
Clarisse Rebancos
Samantha Robertson
Hiroshi Nishimune
Masatoshi Suzuki
Masatoshi Suzuki
author_sort Adam Eckardt
collection DOAJ
description Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by specific loss of motor neurons in the spinal cord and brain stem. Although ALS has historically been characterized as a motor neuron disease, there is evidence that motor neurons degenerate in a retrograde manner, beginning in the periphery at the neuromuscular junctions (NMJs) and skeletal muscle. We recently reported a vesicle trafficking protein Bet1L (Bet1 Golgi Vesicular Membrane Trafficking Protein Like) as a new molecule possibly linked to NMJ degeneration in ALS. In this study, we tested the hypothesis that Bet1L gene silencing in skeletal muscle could influence NMJ integrity, motor neuron function, and survival in a rat model of familial ALS (SOD1G93A transgenic). Small interfering RNA (siRNA) targeting the Bet1L gene was injected on a weekly basis into the hindlimb muscle of pre-symptomatic ALS and wild-type (WT) rats. After 3 weeks, intramuscular Bet1L siRNA injection significantly increased the number of denervated NMJs in the injected muscle. Bet1L knockdown decreased motor neuron size in the lumbar spinal cord, which innervated the siRNA-injected hindlimb. Impaired motor function was identified in the hindlimbs of Bet1L siRNA-injected rats. Notably, the effects of Bet1L knockdown on NMJ and motor neuron degeneration were more significant in ALS rats when compared to WT rats. Together, Bet1L knockdown induces denervation of NMJs, but also this knockdown accelerates the disease progression in ALS. Our results provide new evidence to support the potential roles of Bet1L as a key molecule in NMJ maintenance and ALS pathogenesis.
format Article
id doaj-art-33ba9ee7d34447e1aa3b17df7ae5f060
institution Kabale University
issn 1662-453X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj-art-33ba9ee7d34447e1aa3b17df7ae5f0602025-01-17T06:50:40ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2025-01-011910.3389/fnins.2025.15271811527181Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALSAdam Eckardt0Charles Marble1Bradley Fern2Henry Moritz3Charles Kotula4Jiayi Ke5Clarisse Rebancos6Samantha Robertson7Hiroshi Nishimune8Masatoshi Suzuki9Masatoshi Suzuki10Department of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesNeurobiology of Aging, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, JapanDepartment of Comparative Biosciences, University of Wisconsin-Madison, Madison, WI, United StatesStem Cell and Regenerative Medicine Center, University of Wisconsin-Madison, Madison, WI, United StatesAmyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by specific loss of motor neurons in the spinal cord and brain stem. Although ALS has historically been characterized as a motor neuron disease, there is evidence that motor neurons degenerate in a retrograde manner, beginning in the periphery at the neuromuscular junctions (NMJs) and skeletal muscle. We recently reported a vesicle trafficking protein Bet1L (Bet1 Golgi Vesicular Membrane Trafficking Protein Like) as a new molecule possibly linked to NMJ degeneration in ALS. In this study, we tested the hypothesis that Bet1L gene silencing in skeletal muscle could influence NMJ integrity, motor neuron function, and survival in a rat model of familial ALS (SOD1G93A transgenic). Small interfering RNA (siRNA) targeting the Bet1L gene was injected on a weekly basis into the hindlimb muscle of pre-symptomatic ALS and wild-type (WT) rats. After 3 weeks, intramuscular Bet1L siRNA injection significantly increased the number of denervated NMJs in the injected muscle. Bet1L knockdown decreased motor neuron size in the lumbar spinal cord, which innervated the siRNA-injected hindlimb. Impaired motor function was identified in the hindlimbs of Bet1L siRNA-injected rats. Notably, the effects of Bet1L knockdown on NMJ and motor neuron degeneration were more significant in ALS rats when compared to WT rats. Together, Bet1L knockdown induces denervation of NMJs, but also this knockdown accelerates the disease progression in ALS. Our results provide new evidence to support the potential roles of Bet1L as a key molecule in NMJ maintenance and ALS pathogenesis.https://www.frontiersin.org/articles/10.3389/fnins.2025.1527181/fullamyotrophic lateral sclerosis (ALS)Bet1Lsmall interfering RNA (siRNA)SOD1G93A ratsneuromuscular junctionskeletal muscle
spellingShingle Adam Eckardt
Charles Marble
Bradley Fern
Henry Moritz
Charles Kotula
Jiayi Ke
Clarisse Rebancos
Samantha Robertson
Hiroshi Nishimune
Masatoshi Suzuki
Masatoshi Suzuki
Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS
Frontiers in Neuroscience
amyotrophic lateral sclerosis (ALS)
Bet1L
small interfering RNA (siRNA)
SOD1G93A rats
neuromuscular junction
skeletal muscle
title Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS
title_full Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS
title_fullStr Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS
title_full_unstemmed Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS
title_short Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS
title_sort muscle specific bet1l knockdown induces neuromuscular denervation motor neuron degeneration and motor dysfunction in a rat model of familial als
topic amyotrophic lateral sclerosis (ALS)
Bet1L
small interfering RNA (siRNA)
SOD1G93A rats
neuromuscular junction
skeletal muscle
url https://www.frontiersin.org/articles/10.3389/fnins.2025.1527181/full
work_keys_str_mv AT adameckardt musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT charlesmarble musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT bradleyfern musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT henrymoritz musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT charleskotula musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT jiayike musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT clarisserebancos musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT samantharobertson musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT hiroshinishimune musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT masatoshisuzuki musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals
AT masatoshisuzuki musclespecificbet1lknockdowninducesneuromusculardenervationmotorneurondegenerationandmotordysfunctioninaratmodeloffamilialals